The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | Common | 004225108 | 10,696 | 329,500 | SH | SOLE | 329,500 | 0 | 0 | ||
AGENUS INC | Common | 00847G705 | 12,554 | 3,099,838 | SH | SOLE | 3,099,838 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | Common | 00972D105 | 4,652 | 621,873 | SH | SOLE | 621,873 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common | 03152W109 | 20,195 | 3,698,665 | SH | SOLE | 3,698,665 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | Common | 045396108 | 1,448 | 260,982 | SH | SOLE | 260,982 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 33,685 | 432,972 | SH | SOLE | 432,972 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO. | Common | 110122108 | 32,755 | 445,339 | SH | SOLE | 445,339 | 0 | 0 | ||
CASCADIAN THERAPEUTICS INC | Common | 14740B101 | 5,418 | 5,744,723 | SH | SOLE | 5,744,723 | 0 | 0 | ||
CELATOR PHARMACEUTICALS INC. | Common | 15089R102 | 33,942 | 1,124,666 | SH | SOLE | 1,124,666 | 0 | 0 | ||
CELLECTIS - ADR | Sponsored ADS | 15117K103 | 1,135 | 42,671 | SH | SOLE | 42,671 | 0 | 0 | ||
CORVUS PHARMACEUTICALS INC | Common | 221015100 | 1,067 | 74,800 | SH | SOLE | 74,800 | 0 | 0 | ||
CYTOKINETICS INC. | Common | 23282W605 | 4,782 | 503,900 | SH | SOLE | 503,900 | 0 | 0 | ||
DERMIRA INC | Common | 24983L104 | 21,109 | 721,663 | SH | SOLE | 721,663 | 0 | 0 | ||
FORTRESS BIOTECH INC | Common | 34960Q109 | 3,569 | 1,326,636 | SH | SOLE | 1,326,636 | 0 | 0 | ||
GILEAD SCIENCES INC | Common | 375558103 | 9,051 | 108,500 | SH | SOLE | 108,500 | 0 | 0 | ||
GLOBAL BLOOD THERAPEEUTICS INC | Common | 37890U108 | 15,987 | 963,646 | SH | SOLE | 963,646 | 0 | 0 | ||
IMMUNOMEDICS INC | Common | 452907108 | 19,852 | 8,556,957 | SH | SOLE | 8,556,957 | 0 | 0 | ||
IMMUNOMEDICS INC | Common | 452907108 | 45 | 300,800 | SH | Call | SOLE | 300,800 | 0 | 0 | |
IMMUNOMEDICS INC | Common | 452907108 | 19 | 153,100 | SH | Call | SOLE | 153,100 | 0 | 0 | |
INNOCOLL HOLDINGS PLC | Sh | G4783X105 | 2,579 | 468,148 | SH | SOLE | 468,148 | 0 | 0 | ||
ISh RUSSELL 2000 ETF | Put | 464287955 | 19 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
LA JOLLA PHARMACEUTICAL CO | Common | 503459604 | 1,120 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
LION BIOTECHNOLOGIES INC | Common | 53619R102 | 35,142 | 4,338,557 | SH | SOLE | 4,338,557 | 0 | 0 | ||
MEDIVATION INC | Common | 58501N101 | 16,866 | 279,700 | SH | SOLE | 279,700 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | Common | 60468T105 | 6,633 | 1,214,833 | SH | SOLE | 1,214,833 | 0 | 0 | ||
NANTKWEST INC | Common | 63016Q102 | 450 | 72,412 | SH | SOLE | 72,412 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | Common | 64125C109 | 23,149 | 509,330 | SH | SOLE | 509,330 | 0 | 0 | ||
NEURODERM LTD | Common | M74231107 | 9,051 | 557,003 | SH | SOLE | 557,003 | 0 | 0 | ||
ONCOBIOLOGICS INC | Common | 68235M105 | 1,587 | 466,667 | SH | SOLE | 466,667 | 0 | 0 | ||
ONCOBIOLOGICS INC - WARRANT A | Warrant | 68235M113 | 107 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
ONCOBIOLOGICS INC - WARRANT B | Warrant | 68235M121 | 105 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
PERNIX THERAPEUTICS HOLDINGS INC | Convertible Debt | 71426VAK4 | 1,487 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
RELYPSA INC | Common | 759531106 | 11,346 | 613,300 | SH | SOLE | 613,300 | 0 | 0 | ||
SAREPTA THERAPUTICS INC | Common | 803607100 | 26,930 | 1,412,190 | SH | SOLE | 1,412,190 | 0 | 0 | ||
SAREPTA THERAPUTICS INC | Common | 803607100 | 44 | 5,600 | SH | Call | SOLE | 5,600 | 0 | 0 | |
SAREPTA THERAPUTICS INC | Common | 803607100 | 2,090 | 380,000 | SH | Call | SOLE | 380,000 | 0 | 0 | |
SAREPTA THERAPUTICS INC | Common | 803607100 | 208 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
SAREPTA THERAPUTICS INC | Common | 803607100 | 261 | 139,000 | SH | Call | SOLE | 139,000 | 0 | 0 | |
SAREPTA THERAPUTICS INC | Common | 803607100 | 1 | 2,900 | SH | Put | SOLE | 2,900 | 0 | 0 | |
SAREPTA THERAPUTICS INC | Common | 803607100 | 1,913 | 1,275,600 | SH | Put | SOLE | 1,275,600 | 0 | 0 | |
SAREPTA THERAPUTICS INC | Common | 803607100 | 92 | 53,500 | SH | Put | SOLE | 53,500 | 0 | 0 | |
SORRENTO THERAPEUTICS INC | Common | 83587F202 | 9,270 | 1,655,274 | SH | SOLE | 1,655,274 | 0 | 0 | ||
TELIGENT INC. | Common | 87960W104 | 9,211 | 1,290,000 | SH | SOLE | 1,290,000 | 0 | 0 | ||
TESARO INC | Common | 881569107 | 43,202 | 514,000 | SH | SOLE | 514,000 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | Common | 89620X506 | 2,054 | 228,697 | SH | SOLE | 228,697 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | Common | 921659108 | 7,940 | 709,579 | SH | SOLE | 709,579 | 0 | 0 | ||
VERACYTE INC | Common | 92337F107 | 4,620 | 918,556 | SH | SOLE | 918,556 | 0 | 0 | ||
VERICEL CORP | Common | 92346J108 | 574 | 255,000 | SH | SOLE | 255,000 | 0 | 0 |